Completed PHASE4 INTERVENTIONAL 2-arm NCT03309176

Stair Step Study

Is Endometrial Withdrawal Bleeding Necessary Prior to Ovulation Induction With Clomiphene Citrate? A Randomized Controlled Trial and Feasibility Study

Sponsor: Radboud University Medical Center

Conditions Ovulation Disorder

Interventions Medroxyprogesterone Acetate 10 MG Stair step protocol without Medroxyprogesterone Acetate

Updated 7 times since 2017 Last updated: Jun 4, 2018 Started: Jun 21, 2016 Primary completion: Nov 30, 2017 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03309176, this PHASE4 trial focuses on Ovulation Disorder and remains completed. Sponsored by Radboud University Medical Center, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Mar 2022 [monthly]

Completed PHASE4
Jul 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE4
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ede, Netherlands
• Nijmegen, Netherlands